Predict your next investment

HEALTHCARE | Drug Development
pathwaytx.com

See what CB Insights has to offer

Total Raised

$24.87M

Investors Count

5

Deal Terms

2

Pathway Therapeutics Funding, Pathway Therapeutics Valuation & Pathway Therapeutics Revenue

6 Fundings

Pathway Therapeutics's latest funding round was a Debt for $0.2M on November 30, 2012.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/30/2012

Debt

$0.2M

$0.00B

((9.99x))

FY 1234

1

5/31/2011

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

8/19/2010

Series A - IV

$99M

$0.00B

((9.99x))

FY 1234

10

10/7/2009

Series A - III

$99M

$0.00B

((9.99x))

FY 1234

10

12/19/2008

Series A - II

$99M

$0.00B

((9.99x))

FY 1234

10

Date

11/30/2012

5/31/2011

8/19/2010

10/7/2009

12/19/2008

Round

Debt

Series B

Series A - IV

Series A - III

Series A - II

Amount

$0.2M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Pathway Therapeutics Deal Terms

2 Deal Terms

Pathway Therapeutics's deal structure is available for 2 funding rounds, including their Series B from May 31, 2011.

Round

Series B

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

Pathway Therapeutics Investors

5 Investors

Pathway Therapeutics has 5 investors. GBS Venture Partners invested in Pathway Therapeutics's Debt funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/16/2008

11/30/2012

5
Series A - IV, Series A (2008), Series A - III (2009), Series B (2011), Debt (2012)

Venture Capital

Australia

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Australia

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Non-Profit Foundation

New Zealand

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Academic/University

Australia

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

New Zealand

First funding

6/16/2008

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

11/30/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

5
Series A - IV, Series A (2008), Series A - III (2009), Series B (2011), Debt (2012)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Venture Capital

Venture Capital

Non-Profit Foundation

Academic/University

Venture Capital

Location

Australia

Australia

New Zealand

Australia

New Zealand

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.